Title : Co-administration of the mTORC1/TORC2 inhibitor INK128 and the Bcl-2/Bcl-xL antagonist ABT-737 kills human myeloid leukemia cells through Mcl-1 down-regulation and AKT inactivation.

Pub. Date : 2015 Dec

PMID : 26452980






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Notably, INK128 was more potent than the TORC1 inhibitor rapamycin in down-regulating Mcl-1, diminishing AKT and 4EBP1 phosphorylation, and potentiating ABT-737 activity. Sirolimus CREB regulated transcription coactivator 1 Homo sapiens